Oka S, Akagi Y, Mituyoshi T, Ono K, et al. Successful treatment of myeloid blast phase chronic myelogenous leukemia with the JAK2 V617 F mutation by combination therapy with asciminib and ropeginterferon alfa-2b in an elderly patient. Int J Hematol 2025 Apr 29. doi: 10.1007/s12185-025-03994.
PMID: 40299271